File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/nu6125611
- Scopus: eid_2-s2.0-84915756474
- PMID: 25486369
- WOS: WOS:000346796100014
Supplementary
- Citations:
- Appears in Collections:
Article: Vitamin B12 in obese adolescents with clinical features of insulin resistance
Title | Vitamin B12 in obese adolescents with clinical features of insulin resistance |
---|---|
Authors | |
Keywords | Obesity Vitamin B12 deficiency Adolescents Cobalamin Insulin resistance |
Issue Date | 2014 |
Citation | Nutrients, 2014, v. 6, n. 12, p. 5611-5618 How to Cite? |
Abstract | © 2014 by the authors; licensee MDPI, Basel, Switzerland.Emerging evidence indicates an association between obesity, metformin use and reduced vitamin B12 status, which can have serious hematologic, neurologic and psychiatric consequences. This study aimed to examine B12 status in obese adolescents with pre-diabetes and/or clinical features of insulin resistance. Serum B12 was measured using chemiluminescence immunoassay in 103 (43 male, 60 female) obese (mean body mass index (BMI) z-score ± SD (2.36 ± 0.29)), adolescents aged 10 to 17 years, median (range) insulin sensitivity index of 1.27 (0.27 to 3.38) and 13.6% had pre-diabetes. Low B12 (<148 pmol/L) was identified in eight (7.8%) and borderline status (148 to 221 pmol/L) in an additional 25 (24.3%) adolescents. Adolescents with borderline B12 concentrations had higher BMI z-scores compared to those with normal concentrations (2.50 ± 0.22 vs. 2.32 ± 0.30, p = 0.008) or those with low B12 concentration (2.50 ± 0.22 vs. 2.27 ± 0.226, p = 0.041). In conclusion, nearly a third of obese adolescents with clinical insulin resistance had a low or borderline serum B12 status. Therefore, further investigations are warranted to explore the cause and the impact of low B12 status in obese pediatric populations. |
Persistent Identifier | http://hdl.handle.net/10722/236687 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ho, Mandy | - |
dc.contributor.author | Halim, Jocelyn H. | - |
dc.contributor.author | Gow, Megan L. | - |
dc.contributor.author | El-Haddad, Nouhad | - |
dc.contributor.author | Baur, Louise A. | - |
dc.contributor.author | Cowell, Chris T. | - |
dc.contributor.author | Garnett, Sarah P. | - |
dc.contributor.author | Marzulli, Teresa | - |
dc.date.accessioned | 2016-12-01T09:08:36Z | - |
dc.date.available | 2016-12-01T09:08:36Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Nutrients, 2014, v. 6, n. 12, p. 5611-5618 | - |
dc.identifier.uri | http://hdl.handle.net/10722/236687 | - |
dc.description.abstract | © 2014 by the authors; licensee MDPI, Basel, Switzerland.Emerging evidence indicates an association between obesity, metformin use and reduced vitamin B12 status, which can have serious hematologic, neurologic and psychiatric consequences. This study aimed to examine B12 status in obese adolescents with pre-diabetes and/or clinical features of insulin resistance. Serum B12 was measured using chemiluminescence immunoassay in 103 (43 male, 60 female) obese (mean body mass index (BMI) z-score ± SD (2.36 ± 0.29)), adolescents aged 10 to 17 years, median (range) insulin sensitivity index of 1.27 (0.27 to 3.38) and 13.6% had pre-diabetes. Low B12 (<148 pmol/L) was identified in eight (7.8%) and borderline status (148 to 221 pmol/L) in an additional 25 (24.3%) adolescents. Adolescents with borderline B12 concentrations had higher BMI z-scores compared to those with normal concentrations (2.50 ± 0.22 vs. 2.32 ± 0.30, p = 0.008) or those with low B12 concentration (2.50 ± 0.22 vs. 2.27 ± 0.226, p = 0.041). In conclusion, nearly a third of obese adolescents with clinical insulin resistance had a low or borderline serum B12 status. Therefore, further investigations are warranted to explore the cause and the impact of low B12 status in obese pediatric populations. | - |
dc.language | eng | - |
dc.relation.ispartof | Nutrients | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Obesity | - |
dc.subject | Vitamin B12 deficiency | - |
dc.subject | Adolescents | - |
dc.subject | Cobalamin | - |
dc.subject | Insulin resistance | - |
dc.title | Vitamin B12 in obese adolescents with clinical features of insulin resistance | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3390/nu6125611 | - |
dc.identifier.pmid | 25486369 | - |
dc.identifier.scopus | eid_2-s2.0-84915756474 | - |
dc.identifier.volume | 6 | - |
dc.identifier.issue | 12 | - |
dc.identifier.spage | 5611 | - |
dc.identifier.epage | 5618 | - |
dc.identifier.eissn | 2072-6643 | - |
dc.identifier.isi | WOS:000346796100014 | - |
dc.identifier.issnl | 2072-6643 | - |